Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f21c1009c60308a64b8e7dc0bb989632 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f85af810578fac3d697eb58690a6f7c |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2008-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef21039c66ed571c44494d7fd90f1458 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6100a16862adf19c9ee9253d514fdee7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c675b60fcc48dadfb04877813aec221 |
publicationDate |
2010-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2145900-A1 |
titleOfInvention |
Orai1 (CRACM1) is the platelet SOC channel and essential for pathological thrombus formation |
abstract |
The present invention relates to a pharmaceutical composition comprising an inhibitor of Orai1 or an inhibitor of an activator of Orai1 and optionally a pharmaceutically active carrier, excipient or diluent, for use in treating or preventing a disorder related to venous or arterial thrombus formation. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108562748-A |
priorityDate |
2008-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |